Plain-English translation of NCT06687603 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new screening method called EsoCheck—a small swallowable balloon that gently collects cells from your esophagus in about 5 minutes without needing sedation or a camera down your throat. The cells are then analyzed using a DNA test called EsoGuard to detect Barrett's esophagus, a condition that can lead to a serious type of esophageal cancer. The researchers want to prove this method works well in people who don't have chronic heartburn but are still at risk for developing this cancer.
Esophageal adenocarcinoma is a deadly cancer that is often caught too late. Most people with warning signs (Barrett's esophagus) never get screened because current screening requires an uncomfortable procedure with sedation and is expensive. This trial exists to see if a simple, non-invasive swallowable balloon test can find these warning signs in people who wouldn't normally be offered screening.
You likely qualify if…
You likely don't qualify if…
You would swallow a small capsule containing a deflated balloon, which gently expands in your esophagus to collect cell samples—the whole process takes about 5 minutes and requires no sedation or camera. The sample is then sent to a laboratory where a DNA test analyzes the cells to check for warning signs of cancer. Your participation would happen at the time of a scheduled colonoscopy visit, making it convenient and non-invasive.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States